ABBV wants us to go shortif this stock will move to the next mirror lvl, i will re-enter , the nxet lvl is much stronger, but, hovewer i see my signal to short it now - i will do it also.Shortby Taras_LobodaUpdated 3
After a brutal 17 months, things looking up for ABBVReally nice reversal in ABBV over the past 2+ months. Rose through descending channel resistance AND ascending trendline resistance, then re-tested support and took off. It's probably due for a breather, but I'd be a buyer if it re-tests support once more around $74.Longby NickWA6
Going Into Earnings With A Cup-N-Handle Breakout Under It's BeltFor more on ABBV see notes in Related IdeasLongby Ron-V9
This Dividend Aristocrat Has Seemingly Been Overlooked !Check out this overlooked Cup-n-Handle breakout. The moving averaged are looking good to; this could turn out to be a real winner.Longby Ron-V889
ABBV looking to continue it's upside crawlIn full disclosure I have an open position in this name and will look to add another position on break over the 200 MA. As you can see I've drawn in a pennant that just broke to the upside today, 10/17. I'd keep a tight stop on a new entry at $72.80 at first, then after it's a few $$ in profit I'd trail it with the 200 MA. I'll treat any addition to my position as a completely new trade. A word of additional caution, there was a gap not yet filled back in June. This could act as additional resistance. I have a core position for the dividend which at this point is worth a 5.7% yield (my cost basis in the core position is much lower so my yield is about 6.5%). I'll wait for this stock to recover into the $100 range. (Too much info, LOL) Target on this trade $82.00. Ideas, not trading advice.Longby jaxdogUpdated 1
Abbvie brakes 200SMA ABBV is currently breaking the 200sma, ending a 14 month downtrend. On the next days I will be tracking the next tools: OBV should trend higher to confirm this new uptrend. It still has not done that. 3 candlestick closes above the 200SMA would also be a confirmation signal. by dorfmanmaster1
$ABBV Short PositionFor the public record -- I've taken a short position on $ABBV this morning at $74.32 My reasons are technical, and not sociopolitical, but are too complex to describe on one chart, so I'll not attempt to do so. My opinions and actions are not recommendations to buy or sell any stock, bond, ETF, commodity, or any other financial instrument.Shortby DharanaUpdated 6
ABBV - Buy Position @68.00 Setup Great Buy Position @68 flat. Great yield, great risk to reward ratio. Unfortunately the correction might be cause by the dividend payout, so will finish after the divided payment. Great Investing Entry Point, No TRADE!by mmonterrosa6
ABBV - Strong Buy!I dream to see the formation of the right shoulder. If will give-I will buy without hesitation. The asset is charged powerfully for growth.The wave analysis also gives a good hope to see a decrease within the 2nd wave of growth and, as a consequence, the formation of the right shoulder. Note that the largest volume falls on the 3rd wave, which is one of the main indicators of determining the sub-wavesLongby breaktrooper16
ABBV - Strong Buy!I dream to see the formation of the right shoulder. If will give-I will buy without hesitation. The asset is charged powerfully for growth.The wave analysis also gives a good hope to see a decrease within the 2nd wave of growth and, as a consequence, the formation of the right shoulder. Note that the largest volume falls on the 3rd wave, which is one of the main indicators of determining the sub-wavesLongby breaktrooper111
ABBV with a possible ~3.7% movementThe candle for friday closed green above the cloud and we have an uptrending pattern with the tk crossover. I think it will run up about 3.7% and stop around $75ish which is where we saw previous resistance action on 7/3/19, 7/24/17, and there's the sharp chikou pattern at that price level on 5/28/19.Longby lpflackojUpdated 7
AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvABBV: AbbVie 2019-09-26 20:00:00 AbbVie Receives FDA Approval of MAVYRET® (glecaprevir/pibrentasvir) to Shorten Treatment Duration to Eight Weeks for Treatment-Naïve Patients with Chronic Hepatitis C and Compensated Cirrhosis Across All GenotypesLongby RocketTickers5
shortComing into long term downtrend resistance. Currently at gap but not pushing through and at .618 retracement. Looking for quick short. With S$P looking shaky, we might see more sell pressure Shortby Rayden327943
ABBV - Test the trendlineAs we can see from the chart, the price now is testing the bearish trendline which had stood for months. Besides, ABBV crossed the 70, the old resistance which can only be seen if switching to Weekly chart. Next, the price now is being supported by a bullish trendline. There are 2 strategies: 1. Wait for the price to test the up-ward trendline again, and start a long position. 2. Wait for the price to break the bearish trendline, and go long The target price for both is 76 - to close the gap and meet a strong resistance these months in 2019.Longby ThanhhLong6
ABBV long setupABBV’s innovation outlook is trending up based on a current score of 70 out of 99, outperforming sector average. Jobs growth over the past year has decreased and insiders sentiment is positive. ABBV is an Outperformer in terms of sustainability. It is most exposed to AstraZeneca PLC as its supplier. Over the past 4 quarters ABBV beat earnings estimates 3 times and it pays dividend higher than its peers. For more analysis and articles visit our website.Longby StocktradeC6
ABBV | POT Stock I think it's time to start gaining a position on one of the most popular pot sharesLongby breaktrooper5
ABBV - Might be finished, so now what.For this to work, the price dips into the blue lines and up to the green just under $80 for a 1-3 month play. Longby instructions1012
Good time to buy ABBVIEChart Analyse Based on weekly and monthly chart, we can see an interesting point in the ABBVIE chart. The weekly chart is showing a nice low currently forming. Lets see how we end this week. And if we look at the long term trend, the low sits exactly on the long term trend line. If we look at the monthly timeframe you can see also a nice candle forming. we still have a week to go this month, so lets see what happens. Additionally, this corresponds to Fibonacci zone 78.6 Dividend currently 6.4 % Dividend 6 year growth history good payout ratio 1 year dividend growth 27 % Longby MH77114